Patents by Inventor Tsutomu Sanaka

Tsutomu Sanaka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100187476
    Abstract: This invention provides a safe and highly stable peritoneal dialysate, which causes neither peritoneal membrane disorders nor peritoneal sclerosis associated with frequently repeated peritoneal dialysis treatment, which can protect residual renal functions in chronic renal failure, which inhibits the progress of renal damage over a long period of time, and which enables peritoneal dialysis treatment of diabetic patients. This peritoneal dialysate contains 0.05 to 3.5 w/v % of taurine and 0.1 to 6.5 w/v % of trehalose as osmotic agents and has a pH value adjusted between 6.5-7.5.
    Type: Application
    Filed: August 15, 2007
    Publication date: July 29, 2010
    Inventors: Yasumi Yugari, Tsutomu Sanaka
  • Publication number: 20060079464
    Abstract: [Purpose] It is an objective of the present invention to provide a stable neutral peritoneal dialysate that contains a substance other than glucose to serve as an osmotic agent. [Means to solve the problem] The peritoneal dialysate of the present invention is stable and can be provided in the form of a single solution in one-compartment containers.
    Type: Application
    Filed: May 23, 2003
    Publication date: April 13, 2006
    Inventors: Tsutomu Sanaka, Maki Wakabayashi, Yukihiro Sano
  • Patent number: 6261588
    Abstract: A prophylactic or a remedy for renal diseases comprises a hydrophilic solvent-extract of mushroom as an effective component. The hydrophilic solvent-extract of mushroom according to the present invention possesses an effect of markedly improving and maintaining the renal functions of undialyzed patients suffering from renal disease. Therefore, the extract permits the substantial elimination or retardation of the initiation of any dialytic therapy, which has conventionally been inevitable for the end-stage renal disease patients.
    Type: Grant
    Filed: October 4, 1999
    Date of Patent: July 17, 2001
    Assignee: Ricom Shoji Corp.
    Inventor: Tsutomu Sanaka
  • Patent number: 6153581
    Abstract: Drug which contains human growth hormones capable of recovering the renal function when administered to a patient who has renal insufficiency but has not yet undergone kidney dialysis. By administrating the drug, the loss of renal function represented by an extreme decrease in creatinine clearance or the reciprocal of blood creatinine level can be prevented and thus it can dispense with the dialytic treatment for patients with renal insufficiency.
    Type: Grant
    Filed: March 27, 1998
    Date of Patent: November 28, 2000
    Assignee: Sumitomo Pharmaceuticals Company
    Inventor: Tsutomu Sanaka